Think they still undergoing trials for tourettes Syndrome and by this year end it should be approved. So either this year end or next year it might be available over the counter. But according to a pharmacist I spoke to recently, he says it's making very good progress. It was previously removed from the Emalex web for stuttering and most probably due to not receiving much financial investment support for the problem. I'd personally say it's true because stuttering only affects 1% globally so that isnt enough to get investment in. But if it's approved, then stuttering treatment will be off label that's for sure. They have done few tests on stutterers using Ecopipam and it's worked well, no issues.